DOI QR코드

DOI QR Code

Synthesis and In vitro Evaluation of 99mTc-diglucosediethylenetriamine (DGTA) as a Potential Tumor Imaging Agent

  • Lee, Sang-Ju (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Oh, Seung-Jun (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Jung-Young (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ryu, Jin-Sook (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Seog-Young (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Moon, Dae-Hyuk (Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2011.05.01
  • Accepted : 2011.06.05
  • Published : 2011.07.20

Abstract

Using a single step chemical synthesis, we synthesized the potential tumor imaging agent $^{99m}Tc$-diglucose-diethylenetriamine (DGTA) from diethylenetriamine and natural D-glucose. 10 min Incubation of 10 mg of precursor with 50 ${\mu}g$ of $SnCl_2{\cdot}2H_2O$ at room temperature yielded over 95% of $^{99m}Tc$ labeling. The stability for 6 hours in saline or human plasma was over 90%. In vitro tumor cell uptake assays using the SNU-C5 and 9 L cell lines showed that, in 0-400 mg/dL glucose medium, cell uptake of $^{99m}Tc$-DGTA was 1.5-8 times higher than that of [$^{18}F$]FDG. Moreover, [$^{18}F$]FDG uptake was dependent on glucose concentration in the medium, whereas cellular uptake of $^{99m}Tc$-DGTA was not dependent on glucose concentration, suggesting that the two compounds have different uptake mechanisms by tumor cells.

Keywords

References

  1. Leskinen, S.; Lapela, M.; Lindholm, P.; Minn, H. Ann. Med. 1997,29, 271. https://doi.org/10.3109/07853899708999347
  2. Schiepers, C.; Hoh, C. K. Eur. Radiol. 1998, 8, 1481. https://doi.org/10.1007/s003300050579
  3. Fowler, J. S.; Ido, T. Semin. Nucl. Med. 2002, 32, 6. https://doi.org/10.1053/snuc.2002.29270
  4. Banerjee, S. R.; Maresca, K. P.; Francesconi, L.; Valliant, J.;Babich, J. W.; Zubieta, J. Nucl. Med. Biol. 2005, 32, 1. https://doi.org/10.1016/j.nucmedbio.2004.09.001
  5. Bayly, S. R.; Fisher, C. L.; Storr, T.; Adam, M. J.; Orvig, C.Bioconjug Chem. 2004, 15, 923. https://doi.org/10.1021/bc0499681
  6. Yang, D. J.; Kim, C. G.; Schechter, N. R.; Azhdarinia, A.; Yu, D.F.; Oh, C. S.; Bryant, J. L.; Won, J. J.; Kim, E. E.; Podoloff, D. A.Radiology 2003, 226, 465. https://doi.org/10.1148/radiol.2262011811
  7. Yang, D. J.; Yukihiro, M.; Yu, D. F.; Ito, M.; Oh, C. S.; Kohanim,S.; Azhdarinia, A.; Kim, C. G.; Bryant, J.; Kim, E. E.; Podoloff, D.Cancer Biother. Radio. 2004, 19, 443. https://doi.org/10.1089/cbr.2004.19.443
  8. Oh, S. J.; Ryu, J. S.; Yoon, E. J.; Bae, M. S.; Choi, S. J.; Park, K.B.; Moon, D. H. Appl. Radiat. Isot. 2006, 64, 207. https://doi.org/10.1016/j.apradiso.2005.07.022
  9. Chen, Y.; Huang, Z. W.; He, L.; Zheng, S. L.; Li, J. L.; Qin, D. L.Appl. Radiat. Isot. 2006, 64, 342. https://doi.org/10.1016/j.apradiso.2005.08.004
  10. Chen, X.; Li, L.; Liu, F.; Liu, B. Bioorg. Med. Chem. Lett. 2006,16, 5503. https://doi.org/10.1016/j.bmcl.2006.08.050
  11. Xiong, Q. F.; Chen, Y. Cancer. Biother. Radiopharm. 2008, 23, 376. https://doi.org/10.1089/cbr.2007.0443
  12. Zhang, X.; Xiong, Z.; Wu, Y.; Cai, W.; Tseng, J. R.; Gambhir, S.S.; Chen, X. J. Nucl. Med. 2006, 47, 113.
  13. Wu, Z.; Li, Z. B.; Cai, W.; He, L.; Chin, F. T.; Li, F.; Chen, X. Eur.J. Nucl. Med. Mol. Imaging. 2007, 34, 1823. https://doi.org/10.1007/s00259-007-0427-0
  14. Liu, S.; Hsieh, W. Y.; Jiang, Y.; Kim, Y. S.; Sreerama, S. G.; Chen,X.; Jia, B.; Wang, F. Bioconjug. Chem. 2007, 18, 438. https://doi.org/10.1021/bc0603081
  15. Gaucher, S. P.; Pedersen, S. F.; Leary, J. A. J. Org. Chem. 1999,64, 4012. https://doi.org/10.1021/jo9900331

Cited by

  1. Nuclear Imaging of Glucose Metabolism: Beyond 18 F-FDG vol.2019, pp.None, 2011, https://doi.org/10.1155/2019/7954854